Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.53 |
| ▸ | MEN1 | O00255 | 5/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.52 |
| ▸ | LMNA | P02545 | 4/20 | 0.52 |
| ▸ | MAPT | P10636 | 3/20 | 0.52 |
| ▸ | HTT | P42858 | 3/20 | 0.52 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.52 |
| ▸ | SLC6A3 | Q01959 | 3/20 | 0.50 |
| ▸ | ALOX5 | P09917 | 3/20 | 0.50 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.49 |
| ▸ | HPGD | P15428 | 2/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.48 |
| ▸ | GFER | P55789 | 1/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.48 |
| ▸ | HSP90B1 | P14625 | 1/20 | 0.47 |
| ▸ | FADS1 | O60427 | 1/20 | 0.47 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.47 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28049711 | 0.83 | MEN1 (0.54) | ALDH1A1MEN1KMT2ALMNAMAPT | |
| SCHEMBL4098338 | 0.82 | TRPV1 (0.54) | ALDH1A1MEN1KMT2ALMNAMAPT | |
| SCHEMBL1415617 | 0.81 | SLC6A3 (0.49) | ALDH1A1MEN1KMT2ALMNAMAPT | |
| SCHEMBL3909905 | 0.81 | MAPT (0.53) | ALDH1A1MEN1KMT2ALMNAMAPT | |
| SCHEMBL24702483 | 0.80 | HDAC3 (0.47) | LMNAMAPTHTTSLC6A2SMN1; SMN2 | |
| SCHEMBL7621011 | 0.77 | MAPT (0.49) | ALDH1A1MEN1KMT2ALMNAMAPT | |
| SCHEMBL5928176 | 0.77 | RAB9A (0.62) | ALDH1A1MEN1KMT2ALMNAMAPT | |
| SCHEMBL3908584 | 0.77 | NPC1 (0.49) | ALDH1A1MEN1KMT2AMAPTSLC6A3 | |
| SCHEMBL4098337 | 0.76 | SLC6A3 (0.42) | ALDH1A1MEN1KMT2ALMNAMAPT | |
| SCHEMBL13940844 | 0.76 | AKR1C3 (0.63) | ALDH1A1MEN1KMT2ALMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090017307-A1 | Process for the Preparation of Organic Materials | MCA TECHNOLOGIES, GMBH (CH) | 2009-01-15 | — | — | US | disclosed |
| US-20080060554-A1 | Process for the Preparation of Organic Materials | MCA TECHNOLOGIES, GMBH (CH) | 2008-03-13 | — | — | US | disclosed |
| US-20070119345-A1 | Process for the preparation of organic materials | MCA TECHNOLOGIES, GMBH (CH) | 2007-05-31 | — | — | US | disclosed |
| EP-0654472-B1 | Process for the production of 6,13-dihydroquinacridones | TOYO INK MFG CO (JP) | 2000-03-29 | — | — | EP | disclosed |
| US-5610306-A | ALCOHOL ELIMINATION REACTION OF 2,5-DI(PHENYLAMINO)-3,6--DIHYDROTEREPHTHALIC ACID DIALKYL ESTER; CYCLIZATION | TOYO INK MANUFACTURING CO., LTD. (JP) | 1997-03-11 | — | — | US | disclosed |
| EP-0654472-A1 | Process for the production of 6,13-dihydroquinacridones and apparatus for use for the production | TOYO INK MANUFACTURING CO., LTD. (JP) | 1995-05-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090017307-A1 | Process for the Preparation of Organic Materials | KLK4, PDK4, GRK1 | ALDH1A1 431/4885MEN1 3197/4885KMT2A 2942/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.